(5-Methyl-4-nitro-2 H -pyrazol-3-ylsulfanyl)-acetic acid, 95.0%, 100mg

Bis(4-tert-butylphenyl)iodonium Nonafluoro-1-butanesulfonate>98.0%(HPLC)(T)1g

5-cyclobutyl-1,3,4-oxadiazol-2-amine, 95.0%, 1g

4-Bromo-2-ethylbenzoic acid ethyl ester, 98%, 500mg

9H-Pyrido[3,4-b]indole, 95.0%, 1g

ETHYL 6-CHLORO-1H-INDAZOLE-3-CARBOXYLATE, 95%, 250mg

7-BROMO-5-METHYL-1H-INDAZOLE, 95%, 1g

2-Fluoro-3-formylpyridine, 95.0%, 1g

n-Hexano, mínimo 95 %, para síntesis, 100 ml, envase de vidrio

N-(4-Fluorophenyl)-3-oxo-butyramide, 1g

3-((tert-Butoxycarbonyl)amino)isonicotinic acid, 95.0%, 5g

3-Fluoro-4-nitrotoluene, 99.00%, 10g

1-Phenyl-2,5,8,11-tetraoxatridecan-13-oic acid, 98%, 5g